Target intelligence / Profile preview

MicroRNA 6740 (miR-6740)

Target
miR-6740
Molecular classification
MicroRNA, Non-coding RNA, RNA gene
01

Overview

MicroRNA 6740 (miR-6740), abbreviated as MIR6740, is a short non-coding RNA molecule belonging to the microRNA (miRNA) family, primarily involved in post-transcriptional regulation of gene expression in human cells. MicroRNA 6740 (MIR6740) is a member of the microRNA (miRNA) gene class, defined as a short (approximately 20–24 nucleotides) non-coding RNA molecule, transcribed by RNA polymerase II, processed via Drosha and Dicer ribonucleases into a mature miRNA sequence. Mature miR-6740 can bind target messenger RNA (mRNA) sequences imperfectly, generally resulting in the translational inhibition or destabilization of the target mRNA. The mature miRNA is loaded into the RNA-induced silencing complex (RISC), guiding gene silencing activity; however, the specific mRNA targets and tissue expression patterns of MIR6740 have not been clearly characterized in the literature to date. While miRNAs broadly play roles in fine-tuning expression involved in cell proliferation, apoptosis, and differentiation, no established disease association, clinical biomarker function, or drug target status is recognized for MIR6740 at present. MicroRNA 6740 (miR-6740, MIR6740) is a bona fide human microRNA gene, but it is not a recognized therapeutic target, druggable entity, or validated biomarker; its biological and clinical roles remain poorly defined.

Other names
hsa-mir-6740microRNA 6740MIR6740miR-6740GC01U904138
02

Biological functions

Post-transcriptional regulation of gene expression (destabilization or translational repression of target mRNAs by imperfect base pairing)Candidate regulatory roles in cell differentiation, proliferation, and apoptosis (by analogy to established miRNAs, though MIR6740-specific roles remain unclear)Gene silencing and RNA interference (as part of the RNA-induced silencing complex, RISC)
03

Disease associations

Other (Generic microRNAs have confirmed roles in cancer, immune modulation, and other diseases, but specific disease associations for MIR6740 are not described in the cited databases or literature)

Beyond the preview

Go deeper on MicroRNA 6740 (miR-6740).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 6740 (miR-6740).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call